CVS Health vs Labcorp
Prices at close . Model readings .
CVS Health
$89.95−1.29%- Market value
- $115.77B
- P/E
- 35.7
- 1 year
- +11.6%
Labcorp
$360.25+8.78%- Market value
- $29.54B
- P/E
- 24.5
- 1 year
- +31.7%
Price change, with the S&P 500 as a benchmark
Percent change in each close since the start of the chosen range, for both companies and the S&P 500 (SPY). Daily closes over the last year, weekly before that and monthly before five years.
How the two compare
On the latest closes (28 Oct 2026), CVS Health is the larger company by market value ($115.77B against $29.54B). Over the past year CVS Health returned +11.6% and Labcorp +31.7%, while the S&P 500 returned +12.7%. The latest filed P/E is 35.7 for CVS Health and 24.5 for Labcorp, and the operating margin 4.4% against 12.1%. Over the next 21 sessions the model expects −0.41% for CVS Health, with a 18% chance of a rise, and −0.16% for Labcorp, with a 32% chance. CVS Health's long-run fair value is $87.57, a gap of −2.6% to its price; the long-run model view is neutral. Labcorp's long-run fair value is $343.03, a gap of −4.8% to its price; the long-run model view is neutral.
What the model expects
Expected returns and the chance of a rise from our forecasting models, and the long-run fair value against the price. Readings, not advice.
How the prices moved
Price change over each period, with the S&P 500 (SPY) for comparison.
What the market pays
Size and the multiples from the latest filed quarter. A P/E on losses reads n/m.
How much of revenue becomes profit
Margins and returns on capital from the latest filing; revenue, net income and earnings per share over the trailing twelve months.
How fast the business grew
Change against the same quarter a year earlier.
Balance sheet and quality scores
Leverage, liquidity and two published scores: Altman Z (below 1.8 the distress zone, above 3 the safe zone) and Piotroski F (0 to 9).
How the shares trade
Volatility, sensitivity to the market, the deepest fall, short interest and how closely the two move together.
CVS Health or Labcorp: common questions
Which is larger by market value, CVS Health or Labcorp?
CVS Health, at $115.77B against $29.54B for Labcorp, on the latest closes (28 Oct 2026).
Which has the higher P/E ratio, CVS Health or Labcorp?
CVS Health has the higher latest filed P/E, 35.7; Labcorp's is 24.5. Filings: quarter to 30 Jun 2026.
How did CVS Health and Labcorp move over the past year against the S&P 500?
Over the past year CVS Health returned +11.6% and Labcorp +31.7%, while the S&P 500 returned +12.7%. Prices at close 28 Oct 2026.
What does the model expect for CVS Health and Labcorp over the next month?
−0.41% for CVS Health with a 18% chance of a rise, and −0.16% for Labcorp with a 32% chance, over the next 21 sessions. Model readings 28 Oct 2026. These are model readings, not advice.
How do the operating margins of CVS Health and Labcorp compare?
The operating margin is 4.4% for CVS Health and 12.1% for Labcorp, and the gross margin 44.5% against 29.8%. Filings: quarter to 30 Jun 2026.
Do CVS Health and Labcorp shares move together?
Over the past year the correlation of their daily returns was −0.01 (mostly independent); 1 means they always move together, 0 unrelated, −1 opposite. Prices at close 28 Oct 2026.
Model readings are research estimates, not investment advice. Prices: daily closes. Fundamentals: the latest SEC filings. Short interest: FINRA, settlement 30 Sep 2026. A dash means the figure is not in our data; it is never shown as zero. The model view follows a published rule: next month by the sign of the expected return, the long run positive at a fair value 10% or more above the price and negative at 10% or more below it.